Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review

<b>Objective:</b> To review the efficacy and safety of reduced dose compared to standard dose Enzalutamide treatment for patients with castration-resistant prostate cancer (CRPC). <b>Methods:</b> PubMed, Scopus, Web of Science, and Cochrane databases were searched for randomized controlled trials an...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Zineddine Belabaci, Lucas Mose, Omar El-Taji, Zina Otmani, Zein Alabdin Hannouneh, Issa Mohamad, Thomas Zilli, Osama Mohamad, Nadeem Pervez, Waleed Arafat, Ursula Vogl, Mohamed Shelan
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-05-01
Sarja:	Pharmaceuticals
Aiheet:	castration-resistant prostate cancer enzalutamide dose efficacy adverse events
Linkit:	https://www.mdpi.com/1424-8247/18/5/732
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!